Finance and Control, Franciscus Gasthuis en Vlietland, Rotterdam, Zuid-Holland, Netherlands
Department of Geriatrics, Franciscus Gasthuis en Vlietland, Rotterdam, Zuid-Holland, Netherlands.
BMJ Open. 2024 May 1;14(5):e080257. doi: 10.1136/bmjopen-2023-080257.
The objective is to develop a pragmatic framework, based on value-based healthcare principles, to monitor health outcomes per unit costs on an institutional level. Subsequently, we investigated the association between health outcomes and healthcare utilisation costs.
This is a retrospective cohort study.
A teaching hospital in Rotterdam, The Netherlands.
The study was performed in two use cases. The bariatric population contained 856 patients of which 639 were diagnosed with morbid obesity body mass index (BMI) <45 and 217 were diagnosed with morbid obesity BMI ≥45. The breast cancer population contained 663 patients of which 455 received a lumpectomy and 208 a mastectomy.
The quality cost indicator (QCI) was the primary measures and was defined asQCI = (resulting outcome * 100)/average total costs (per thousand Euros)where average total costs entail all healthcare utilisation costs with regard to the treatment of the primary diagnosis and follow-up care. Resulting outcome is the number of patients achieving textbook outcome (passing all health outcome indicators) divided by the total number of patients included in the care path.
The breast cancer and bariatric population had the highest resulting outcome values in 2020 Q4, 0.93 and 0.73, respectively. The average total costs of the bariatric population remained stable (avg, €8833.55, min €8494.32, max €9164.26). The breast cancer population showed higher variance in costs (avg, €12 735.31 min €12 188.83, max €13 695.58). QCI values of both populations showed similar variance (0.3 and 0.8). Failing health outcome indicators was significantly related to higher hospital-based costs of care in both populations (p <0.01).
The QCI framework is effective for monitoring changes in average total costs and relevant health outcomes on an institutional level. Health outcomes are associated with hospital-based costs of care.
基于价值医疗原则,制定一个实用框架,以监测机构层面的单位成本健康结果。随后,我们调查了健康结果与医疗保健利用成本之间的关联。
这是一项回顾性队列研究。
荷兰鹿特丹的一家教学医院。
该研究在两个用例中进行。减重人群包含 856 名患者,其中 639 名患者被诊断为病态肥胖,体重指数(BMI)<45,217 名患者被诊断为病态肥胖,BMI≥45。乳腺癌人群包含 663 名患者,其中 455 名患者接受了乳房肿块切除术,208 名患者接受了乳房切除术。
质量成本指标(QCI)是主要测量指标,定义为 QCI =(结果*100)/平均总成本(每千欧元),其中平均总成本涉及与主要诊断和随访护理相关的所有医疗保健利用成本。结果是达到教科书结果(通过所有健康结果指标)的患者人数除以纳入护理路径的患者总数。
乳腺癌和减重人群在 2020 年第四季度的结果值最高,分别为 0.93 和 0.73。减重人群的平均总成本保持稳定(平均€8833.55,最小€8494.32,最大€9164.26)。乳腺癌人群的成本波动较大(平均€12735.31,最小€12188.83,最大€13695.58)。两个人群的 QCI 值都表现出类似的波动(0.3 和 0.8)。两个人群的健康结果指标失败与更高的住院护理成本显著相关(p<0.01)。
QCI 框架可有效监测机构层面平均总成本和相关健康结果的变化。健康结果与住院护理成本相关。